Initial testing (stage 1) of the tubulin binding agent nanoparticle albumin-bound (nab) paclitaxel (Abraxane(®)) by the Pediatric Preclinical Testing Program (PPTP)
儿科临床前试验计划 (PPTP) 对微管蛋白结合剂纳米颗粒白蛋白结合 (nab) 紫杉醇 (Abraxane(®)) 进行了初步试验（第一阶段）。
期刊:Pediatric Blood & Cancer
影响因子:2.3
doi:10.1002/pbc.25474
Houghton, Peter J; Kurmasheva, Raushan T; Kolb, E Anders; Gorlick, Richard; Maris, John M; Wu, Jianrong; Tong, Zeen; Arnold, Michael A; Chatterjee, Moumita; Williams, Terence M; Smith, Malcolm A
